Literature DB >> 6193858

Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma.

P Isaacson, D H Wright.   

Abstract

As illustrated in the two cases described in this paper close morphologic and immunohistochemical similarities exist between Mediterranean lymphoma (MTL) and primary gastrointestinal lymphoma of follicle center cell (FCC) origin as it occurs in Western countries. Similarities between the two conditions include a dense noninvasive monotypic lamina propria plasma cell infiltrate, present in all cases of MTL and in some cases of Western gastrointestinal FCC lymphoma, and an invasive infiltrate of FCCs morphologically distinct from the plasma cells. A distinctive lesion produced by individual gland invasion characterizes both types of lymphoma. A clonal relationship between the lamina propria plasma cells and the invasive FCCs, long suspected but never proved in MTL, can be demonstrated in Western cases. Many of the histologic and clinical features common to these lymphomas can be explained in the context of the normal maturation sequences of gut associated lymphoid tissue. It is suggested that MTL and Western cases of primary FCC gastrointestinal lymphoma share a common histogenesis from mucosa associated lymphoid tissue.

Entities:  

Mesh:

Year:  1983        PMID: 6193858     DOI: 10.1002/1097-0142(19831015)52:8<1410::aid-cncr2820520813>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  260 in total

1.  Metastatic gastric maltoma: a rare cause of obscure gastrointestinal bleeding.

Authors:  J A Bailey; M Giacaman; J Visconti; C H Dunphy; W E Longo
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

2.  Superantigens and autoantigens may be involved in the pathogenesis of gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  T Hashimoto; M Takishita; M Kosaka; T Sano; T Matsumoto
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

3.  Distinction between "high grade MALT" and diffuse large B cell lymphoma. Mucosa associated lymphoid tissue.

Authors:  S Ely
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

4.  Helicobacter-independent, chemotherapy-resistant, radiosensitive gastric MALT lymphoma with massive deposits of amyloidlike substance.

Authors:  Hiroshi Matsumoto; Hideki Koga; Mitsuo Iida; Hiroshi Suekane; Ken-Ichi Tarumi; Kazunori Hoshika; Yoshiki Mikami; Ken Haruma
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

Review 5.  Therapy of non-Hodgkin's lymphoma.

Authors:  J Coffey; D C Hodgson; M K Gospodarowicz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-12       Impact factor: 9.236

6.  Clinicopathologic features of surgically resected primary gastric lymphoma.

Authors:  Seong-Ho Kong; Min-A Kim; Do-Joong Park; Hyuk-Joon Lee; Hye-Seung Lee; Chul-Woo Kim; Han-Kwang Yang; Dae-Seog Heo; Kuhn-Uk Lee; Kuk-Jin Choe
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

7.  [Reflections of a Virchow medal laureate].

Authors:  H K Müller-Hermelink
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

8.  Primary duodenal mucosa-associated lymphoid tissue (MALT) lymphoma--a rare presentation of gastric outlet obstruction.

Authors:  Tamar Tadmor; Tova Rainis; Jacob Bejar; Dina Attias; Alexandra Lavy
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

9.  Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases.

Authors:  Sarah E Coupland; Martin Hellmich; Claudia Auw-Haedrich; William R Lee; Harald Stein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-18       Impact factor: 3.117

10.  Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis.

Authors:  Stefan K Drexler; Luca Bonsignore; Mark Masin; Aubry Tardivel; Rene Jackstadt; Heiko Hermeking; Pascal Schneider; Olaf Gross; Jurg Tschopp; Amir S Yazdi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.